Herrera JC, Ibilibor C, Wang H, Mansour AM, et al. National trends and impact of regionalization of radical cystectomy on survival outcomes in patients with muscle invasive bladder cancer. Clinical Genitourinary Cancer. 2020;18(6): e762-e770. (https://doi.org/10.1016/j.clgc.2020.05.012)
Kates M, Mansour AM, Lamm DL, et al. Phase 1/2 trial results of a large surface area microparticle docetaxel for the treatment of high-risk nonmuscle-invasive bladder cancer. The Journal of Urology. 2022;208(4):821-829. (https://doi.org/10.1097/JU.0000000000002778)
Dursun F, Elshabrawy A, Wang H, Mansour AM, et al. Histological variants of non–muscle invasive bladder cancer: survival outcomes of radical cystectomy vs. bladder preservation therapy. In: Vol 40. Elsevier; 2022:275-e1.(https://doi.org/10.1016/j.urolonc.2022.02.004)
Elshabrawy A, Wang H, Satsangi A, Mansour AM, et al. Correlates of refusal of radical cystectomy in patients with muscle-invasive bladder cancer. In: Vol 39. Elsevier; 2021:236-e9. (https://doi.org/10.1016/j.urolonc.2020.11.023)
Hayn MH, Hussain A, Mansour AM, et al. The learning curve of robot-assisted radical cystectomy: results from the International Robotic Cystectomy Consortium. European Urology. 2010;58(2):197-202. (https://doi.org/10.1016/j.eururo.2010.04.024)